爵士制药周二发布了二季度财报，数据显示，公司营收高于分析师的预期，每股收益低于分析师的预期。
在该公司发布的最新财报中，公司每股收益为$-8.25，总营收为$1.05B，而此前对分析师的调查显示，预期该公司的营收为$1.04B，每股收益为$-7.62.
今年以来，爵士制药的股价累计下跌8%。
爵士制药周二发布了二季度财报，数据显示，公司营收高于分析师的预期，每股收益低于分析师的预期。
在该公司发布的最新财报中，公司每股收益为$-8.25，总营收为$1.05B，而此前对分析师的调查显示，预期该公司的营收为$1.04B，每股收益为$-7.62.
今年以来，爵士制药的股价累计下跌8%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.